Download: Affinity issues of ADCs

Download this presentation here > The European Antibody Congress  brings together big pharma, big biotech, SME Biotech, academia, regulators and the wider service provider community to discuss the latest R&D and advances in the antibody space – across mAbs, ADCs, bispecifics, multispecifics, and protein scaffolds. At the 2013 event, delegates were fortunate enough to hear from Dr Richard Schasfoort, Chief Scientific Officer, Ibis Technologies, who delivered …

The perfect fit for your process. CaptureSelect® – custom designed affinity ligands for any purification challenge

CaptureSelect® technology enables new opportunities in the biotherapeutic purification field. BAC has developed a unique affinity ligand discovery program, which has proven itself for a wide variety of target biotherapeutic compounds, ranging from antibodies and antibody fragments, recombinant and plasma proteins to viral particles. CaptureSelect ligands (single domain [VHH] antibody fragments) can be developed for almost any purification challenge, and …